Clinical trial Recruiting at 1 site Observational Ages Any age to 18

International Pediatric Stroke Study for infants and children

Official title: International Pediatric Stroke Study

Run by The Hospital for Sick Children · NCT00084292 · Data updated 2026-11-12

This study is gathering information about infants and children who have had strokes or are at risk for them to help improve treatment and outcomes for pediatric stroke care.

Quick facts

Study typeObservational
AgesAny age to 18 Years
SexAll
Enrollment12000 (estimated)
SponsorThe Hospital for Sick Children
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJanuary 2003
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedMay 15, 2025
Trial IDNCT00084292 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include infants and children up to 18 years old diagnosed with ischemic or hemorrhagic strokes or those at high risk for stroke.

Probably not a fit

Patients who are premature and diagnosed with certain stroke types or those who refuse consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The International Pediatric Stroke Study (IPSS) is a global registry established to collect and analyze data on infants and children who have experienced strokes or are at high risk for them. This multi-center, multi-national initiative involves over 100 institutions worldwide and aims to improve understanding, prevention, and outcomes of pediatric strokes. Participants' medical records are reviewed and entered into a secure database, allowing for collaborative research and analysis of stroke characteristics, treatment, and outcomes. The study focuses on building a comprehensive dataset to facilitate future research and clinical trials in pediatric stroke care.

Why it matters

Potential benefit: If successful, this study could lead to improved prevention and treatment strategies for pediatric strokes, ultimately enhancing patient outcomes.

How similar studies have gone: Other studies have shown success in similar approaches, but the IPSS represents a novel and comprehensive effort in pediatric stroke research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

This registry will include all children from birth to 18 years of age who are diagnosed with stroke or a condition/disease (as defined below) that put them at high risk of stroke after Jan 1,2003 at one of the IPSS participating sites.

This registry will include children diagnosed with below stroke types:

* Arterial Ischemic Stroke (AIS),
* Cerebral Sinovenous Thrombosis (CSVT),
* AIS and CSVT
* Presume Preinatal Ischemic Stroke (PPIS)
* Children diagnosed with hemorrhagic stroke

Children at high risk of stroke include:

* Those diagnosed with arteriopathy, arteritis/vasculitis, moyamoya, dissection, sickle cell related infarcts).
* Brain arteriovenous malformations

Exclusion Criteria:

* Premature children diagnosed with AIS.
* Premature children diagnosed with PPIS
* Children diagnosed with TIA (Transient Ischemic Attack)
* Brain hemorrhage secondary to trauma
* Refusal to provide consent for participation

Where it's running

  • Hospital For Sick Children
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Transcutaneous vagus nerve stimulation with modified constraint-induced movement therapy for chronic stroke

    This study will try noninvasive vagus nerve stimulation together with modified constraint-induced movement therapy to improve arm movement, thinking, and quality of life in people with chronic left-sided stroke and moderate-to-severe arm weakness.

    Recruiting at 2 sites Riphah International University · Rawalpindi, Punjab Province and 1 other locations · NCT07272239

  • Using exoskeletons for long-term rehabilitation of lower limb weakness

    This study is testing whether a hands-free exoskeleton can help adults with lower limb weakness from conditions like stroke or spinal cord injury improve their walking, balance, and quality of life over time.

    Recruiting Wandercraft · Paris · NCT06538974

  • Registry for patients with kidney disease and heart issues

    This study collects information from adults with kidney disease and heart problems to see how their treatments and outcomes differ, helping us understand their health better.

    Recruiting Queen Mary University of London · London · NCT06521801

  • Training to improve arm and hand function after stroke

    This study is testing a special training program to see if it can help people who have had a stroke improve their arm and hand function better than a regular home exercise program.

    Recruiting University Health Network, Toronto · Toronto, Ontario · NCT06498011

  • Biobank of stem cells and biomarkers for cardiovascular disease

    This study is creating a bank of stem cells and blood samples from people with heart disease to help researchers learn more about the condition and find better treatments.

    Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06371937

  • Neurofeedback for improving motor recovery after stroke

    This study tests if a new type of brain training called neurofeedback can help people recover movement in their arms after a stroke.

    Recruiting University Hospital, Toulouse · Toulouse · NCT06212219

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.